Analyst Price Target is $34.64
▲ +58.88% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Privia Health Group in the last 3 months. The average price target is $34.64, with a high forecast of $41.00 and a low forecast of $26.00. The average price target represents a 58.88% upside from the last price of $21.80.
Current Consensus is
The current consensus among 9 contributing investment analysts is to buy stock in Privia Health Group. This Buy consensus rating has held steady for over two years.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.